NCT07754955

Brief Summary

The goal of this clinical trial is to learn whether a new endoscopic device called the Speedboat works as well or better than the standard needle knife for removing large colonic nonpedunculated polyps. The study will also evaluate the safety of the Speedboat device. The main aims of the study are:

  • To compare the resection speed of colorectal endoscopic submucosal dissection (ESD) using the Speedboat device versus the standard needle knife.
  • To compare the en bloc resection rate and curative (R0) resection rate between the two techniques.
  • To evaluate the safety of using the Speedboat device compared with the needle knife in colorectal ESD. What will happen in this study Adults aged 18 years or older who have a large, flat colorectal polyp (greater than 20 mm) that cannot be safely removed with standard snare polypectomy may take part. Participants will be randomly assigned (like flipping a coin) to one of two groups:
  • Speedboat group: The lesion will be removed using the Speedboat device, which combines injection, cutting, and bleeding control in one tool.
  • Needle knife group: The lesion will be removed using the standard needle knife and other separate tools for injection and hemostasis. What participants will do Stay one night in the hospital before the colonoscopy for bowel preparation. Undergo colonoscopy and lesion removal under anesthesia. Have blood tests and monitoring for one day after the procedure. Be followed for two weeks to check for any complications. Have a follow-up colonoscopy 6-12 months later, depending on pathology results. Where and how the study will be done The study will take place at five hospitals in Thailand: Faculty of Medicine Siriraj Hospital, Mahidol University King Chulalongkorn Memorial Hospital Rajavithi Hospital National Cancer Institute of Thailand Phra Nakhon Si Ayutthaya Hospital About 80 participants will join the study. All procedures will be performed by experienced endoscopists who have performed at least 50 colorectal ESD cases.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
13mo left

Started Oct 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress62%
Oct 2024Sep 2027

Study Start

First participant enrolled

October 4, 2024

Completed
1.8 years until next milestone

First Submitted

Initial submission to the registry

August 5, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 10, 2026

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 30, 2027

Expected
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2027

Last Updated

August 10, 2026

Status Verified

October 1, 2025

Enrollment Period

2.5 years

First QC Date

August 5, 2026

Last Update Submit

August 5, 2026

Conditions

Keywords

Endoscopic submucosal dissection, needle knfe, Speedboat

Outcome Measures

Primary Outcomes (1)

  • The resection speed of colorectal endoscopic submucosal dissection using a Speedboat device compared with the standard needle knife.

    Resection speed was calculated using the following formulation. Resection speed = ((specimen diameter in the long axis, mm) x (specimen diameter in the short axis, mm) x 3.14 x 0.25) /procedure time (min). In case of patients with multiple lesions, the biggest lesion will be included in the study

    During the procedure

Secondary Outcomes (2)

  • The en bloc resection rate and curative resection(R0) rate between using Speedboat and needle knife in colorectal ESD

    2 weeks after procedure

  • The intraprocedural and postprocedural complications of using Speedboat and needle knife in colorectal ESD.

    30-days after procedure

Study Arms (2)

Speedboat group

EXPERIMENTAL

The lesion will be removed using the Speedboat device, which combines injection, cu

Device: Speedboat

Needle knife group

ACTIVE COMPARATOR

The lesion will be removed using the standard needle knife and other separate tools for injection and hemostasis.

Device: Needle knife

Interventions

SpeedboatDEVICE

ESD procedure was performed using conventional, pocket-creation, or tunnel methods, depending on the endoscopist's decision. Speedboat group, any of the 2.8, 3.2, or 3.7 mm Speedboat devices is used in all procedure steps, including submucosal injection, mucosal incision, submucosal dissection, and vessel coagulation. A 25G injection needle can be used to initiate the submucosal injection in the case of using a 2.8 mm Speedboat device. If any devices other than Speedboat were used in the procedure, those should be recorded.

Speedboat group

ESD procedure was performed using conventional, pocket-creation, or tunnel methods, depending on the endoscopist's decision. In needle knife gropu, a 25G injection needle is used in the initial submucosal injection step. A 1.5 mm needle knife is used for mucosal incision, submucosal dissection, and additional submucosal injection. Coagrasper is used for coagulating submucosal vessels. All used devices were recorded.

Needle knife group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18 or above with large non-pedunculated colorectal polyp size \> 20 mm. in which 1st endoscopist decided that lesion cannot be resected with endoscopic mucosal resection to achieve en bloc resection

You may not qualify if:

  • Patients who have coagulopathy which is contraindicated for colonoscopy and polypectomy (Prothrombin time \> 3-second ULN, INR \> 1.5, Platelet \< 50,000)
  • The non-pedunculated lesion that was recurrence from the previous polypectomy or ESD
  • Suspected deep submucosal invasion using image-enhanced endoscopy by expert endoscopist
  • Patients who were diagnosed with inflammatory bowel disease
  • Pregnancy or breastfeeding
  • A patient who is unable to provide consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Division of Gastroenterology, Departmnt of Medicine, Faculty of Medicine Siriraj Hospital

Bangkok Noi, Bangkok, 10700, Thailand

RECRUITING

Central Study Contacts

Dr. Onuma Sattayalertyanyong, MD.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

August 5, 2026

First Posted

August 10, 2026

Study Start

October 4, 2024

Primary Completion (Estimated)

March 30, 2027

Study Completion (Estimated)

September 30, 2027

Last Updated

August 10, 2026

Record last verified: 2025-10

Locations